Connor, Clark & Lunn Investment Management (CC&L)’s Genocea Biosciences, Inc. GNCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,214
| Closed | -$91K | – | 1041 |
|
|
2016
Q3 | $91K | Sell |
2,214
-1,526
| -41% | -$62.7K | ﹤0.01% | 781 |
|
|
2016
Q2 | $123K | Sell |
3,740
-3,351
| -47% | -$110K | ﹤0.01% | 784 |
|
|
2016
Q1 | $439K | Sell |
7,091
-747
| -10% | -$46.2K | ﹤0.01% | 595 |
|
|
2015
Q4 | $330K | Buy |
7,838
+4,300
| +122% | +$181K | ﹤0.01% | 611 |
|
|
2015
Q3 | $194K | Buy |
+3,538
| New | +$194K | ﹤0.01% | 645 |
|